INDICATION
DOVATO is indicated as a complete regimen to treat HIV-1 infection in adults with no antiretroviral (ARV) treatment history or to replace the current ARV regimen in those who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable ARV regimen with no history of treatment failure and no known resistance to any component of DOVATO.

Register to Talk
to the Experts

Read more »

DISCOVER DOVATO

TANGO Trial

See trial results for a switch to DOVATO in appropriate virologically suppressed adults

LEARN MORE

GEMINI 1 & 2 Trials

See trial results and 96-week long-term data

SEE LONG-TERM DATA
STAT icon

Rapid Initiation Trial

See trial results using DOVATO in a rapid initiation study

LEARN MORE

Hear Real Patient Stories

A DEEPER LOOK AT DOVATO

Request a Rep

Request a visit from a ViiV Healthcare representative in your area

REQUEST NOW

Email Updates

Sign up to get the latest updates on DOVATO

SIGN UP NOW

ViiV Medical Information

View our medical information library if you have a question about DOVATO

LEARN MORE

DLLWCNT200029